Age-Dependent Variation in Glycosylation Features of Alpha-2-Macroglobulin

被引:9
|
作者
Calvert, Laura [1 ]
Atkinson, Helen [1 ]
Berry, Leslie [1 ]
Chan, Anthony [1 ]
机构
[1] McMaster Univ, Dept Pediat, Thrombosis & Atherosclerosis Res Inst, 237 Barton St East, Hamilton, ON L8L 2X2, Canada
关键词
Alpha-2-macroglobulin; Glycosylation; Plasma; Newborn; THROMBIN; BINDING; PROTEIN; ALPHA(2)-MACROGLOBULIN; PLASMA; SYSTEM;
D O I
10.1007/s12013-019-00883-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alpha-2-macroglobulin (A2M) is a glycosylated broad spectrum inhibitor of numerous proteases, including those involved in blood coagulation. Glycosylation characteristics can affect protein structure and function. This study compares glycosylation characteristics of A2M in newborn umbilical cord (NUCP) and adult pooled plasmas. Peptide N-Glycosidase F treatment was used to evaluate the total N-glycan content of the molecules. Neuraminidase treatment, and affinity for Ricinus Communis Agglutinin I were used to examine terminal sialic acid and galactose content, respectively. Two-dimensional (2D) electrophoresis was used to determine charge-related isoform profiles and fluorophore-assisted carbohydrate electrophoresis (FACE) was used to characterize N-glycan profiles. Results revealed no difference in total N-glycan mass, however, a statistically significant difference was shown in the change in charge associated with sialic acid loss in the NUCP A2M population. 2D electrophoresis indicated a lower pI range for NUCP A2M isoforms. In addition, NUCP A2M displayed a trend toward higher terminal galactose quantities than adult A2M. FACE revealed an increased abundance of more branched, higher molecular weight glycans in NUCP A2M. These differences in glycan branching and charged residues may impact A2M receptor-based clearance and thus could be responsible for the increased A2M concentration seen in NUCP, and newborns.
引用
收藏
页码:335 / 342
页数:8
相关论文
共 50 条
  • [21] STRUCTURE OF THE ALPHA-2-MACROGLOBULIN RECEPTOR
    STRICKLAND, DK
    ASHCOM, JD
    WILLIAMS, S
    BURGESS, WH
    MIGLIORINI, M
    ARGRAVES, WS
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1991, 372 (03): : 147 - 147
  • [22] ANTIPROTEINASE ACTIVITY OF ALPHA-2-MACROGLOBULIN
    PROTSENKO, AV
    UKRAINSKII BIOKHIMICHESKII ZHURNAL, 1984, 56 (05): : 546 - 549
  • [23] BIOSYNTHESIS OF RAT ALPHA-2-MACROGLOBULIN
    NORTHEMANN, W
    HEISIG, M
    KUNZ, D
    BAUER, J
    BIRMELIN, M
    TRANTHI, TA
    DECKER, K
    HEINRICH, PC
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1985, 13 (02) : 285 - 288
  • [24] REACTIVE CENTERS IN ALPHA-2-MACROGLOBULIN
    HOWARD, JB
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1983, 421 (DEC) : 69 - 80
  • [25] THE CLINICAL RELEVANCE OF ALPHA-2-MACROGLOBULIN
    DONNELLY, PK
    SHENTON, BK
    ALOMRAN, A
    FRANCIS, DMA
    PROUD, G
    TAYLOR, RMR
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1983, 421 (DEC) : 382 - 387
  • [26] PRIMARY STRUCTURE OF ALPHA-2-MACROGLOBULIN
    SOTTRUPJENSEN, L
    STEPANIK, TM
    LONBLAD, P
    RIDER, DM
    PETERSEN, TE
    MAGNUSSON, S
    THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 87 - 87
  • [27] INHIBITION OF KERATINASES BY ALPHA-2-MACROGLOBULIN
    YU, RJ
    BLANK, F
    GRAPPEL, SF
    EXPERIENTIA, 1972, 28 (08): : 886 - &
  • [28] EFFECTS OF ALPHA-2-MACROGLOBULIN ON DIC
    IGARASHI, M
    TAKATSUKA, J
    ASADA, T
    ACTA HAEMATOLOGICA JAPONICA, 1978, 41 (06): : 1118 - 1122
  • [29] PARTICIPATION OF ALPHA-2-MACROGLOBULIN IN COUNTERIRRITATION
    SILVEIRA, VLF
    LIMAOS, EA
    AGENTS AND ACTIONS, 1992, 36 (3-4): : 294 - 299
  • [30] IMMUNOLOCALIZATION OF ALPHA-2-MACROGLOBULIN TO THE DERMIS
    FELDMAN, SR
    GAMMON, WR
    CLINICAL RESEARCH, 1988, 36 (03): : A644 - A644